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Abstract: A comparative study between two novel, highly
water soluble, ruthenium(II) polypyridyl complexes, [Ru(-
phen)2L’] and [Ru(phen)2Cu(II)L’] (L and L-Cu
II), containing
the polyaazamacrocyclic unit 4,4’-(2,5,8,11,14-pentaaza[15])-
2,2’-bipyridilophane (L’), is herein reported. L and L-CuII in-
teract with calf-thymus DNA and efficiently cleave DNA plas-
mid when light-activated. They also possess great penetra-
tion abilities and photo-induced biological activities, evaluat-
ed on an A375 human melanoma cell line, with L-CuII being
the most effective. Our study highlights the key role of the
Fenton active CuII center within the macrocycle framework,
that would play a synergistic role with light activation in the
formation of cytotoxic ROS species. Based on these results,
an optimal design of RuII polypyridyl systems featuring spe-
cific CuII-chelating polyamine units could represent a suita-
ble strategy for the development of novel and effective pho-
tosensitizers in photodynamic therapy.
Introduction
In recent years, photodynamic therapy (PDT) has received in-
creasing attention due to the encouraging responses of its ap-
plication in the treatment of a wide variety of cancers, includ-
ing lung, bladder, esophageal and skin tumors, as well as in
bacterial infections.[1–4]
PDT relies on the use of a photosensitizer agent (PS), that
can be triggered by irradiation with low-energy light to gener-
ate cytotoxic species, such as reactive oxygen species (ROS),
thus providing a complete spatial and temporal control over
the generation of the toxic molecule.[5] Generally, light-activat-
ed PSs can react with the molecular oxygen leading to the for-
mation of ROS through two distinct pathways. In accordance
with a Type I reaction, the triplet excited state of the PS can
determine a direct electron or proton transfer to the surround-
ing biological substrates, inducing the formation of radicals
that can further interact with molecular oxygen to form ROS,
such as superoxide, hydroxyl radicals or peroxides. In Type II
mechanisms, an energy transfer from the triplet excited state
of the PS to ground-state molecular oxygen (3O2) can occur,
bringing to the production of extremely cytotoxic singlet
oxygen (1O2). This species, with an estimated half-life of 40 ns
in a biological environment,[6] represents a very reactive form
of oxygen and can rapidly react with biological targets, deter-
mining topical oxidative damages that can ultimately induce
the cellular death.
The light-induced production of 1O2 plays a key role in the
development of PS for PDT. In fact, the great majority of the
PSs that are currently applied in clinics mainly rely on Type II
mechanism,[7] and are based on cyclic tetrapyrrolic scaffolds,
namely porphirins, phthalocyanins, and chlorins.[8] However,
the performances of these molecules are often limited by im-
portant disadvantages, such as low solubility in biological
media, poor selectivity and prolonged patient photosensitivity,
as in the case of Photofrin, used for the treatment of lung
and esophageal cancers.[9] As consequence, many efforts have
been undertaken to move away from tetrapyrrolic systems,
making appealing the exploration of transition metal com-
plexes as potential PDT agents. In this context, ruthenium(II)
polypyridyl complexes are attracting much interest due to the
rich photoluminescence repertoire, DNA binding ability, redox
chemistry, and tunable absorption properties.[10–11]
In particular, their 3MLCT (metal to ligand charge transfer)
state can be easily quenched by molecular oxygen to generate
singlet oxygen with good quantum yields, as in the case of
[a] Dr. L. Conti, Prof. A. Bencini, Dr. C. Gellini, Prof. G. Pietraperzia,
Prof. B. Valtancoli, Prof. C. Giorgi
Department of Chemistry ‘Ugo Schiff’
University of Florence
Via della Lastruccia 3, 50019, Sesto Fiorentino (FI) (Italy)
E-mail : luca.conti@unifi.it
claudia.giorgi@unifi.it
[b] Prof. C. Ferrante
Department of Chemical Sciences and UR INSTM
University of Padova
via Marzolo 1, 35131, Padova (PD) (Italy)
[c] Prof. P. Paoli, Dr. M. Parri
Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
University of Florence
Viale Morgagni 50, Firenze (FI) (Italy)
[d] Prof. G. Pietraperzia
European Laboratory for Non Linear Spectroscopy (LENS)
University of Florence
via Nello Carrara 1, 50019, Sesto Fiorentino (FI) (Italy)
Supporting information and the ORCID identification number(s) for the au-
thor(s) of this article can be found under:
https://doi.org/10.1002/chem.201901570.
Chem. Eur. J. 2019, 25, 1 – 11  2019 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim1 &&
These are not the final page numbers! ÞÞ
Full PaperDOI: 10.1002/chem.201901570
[Ru(bpy)3]
2+ (bpy=2,2’-bipyridine), that showed a great ability
to induce apoptosis of cancer cells in presence of light, al-
though the scarce selectivity and low DNA binding affinity lim-
ited its further application as PDT agent.[12] One of the most im-
portant class of anticancer drugs among ruthenium(II) poly-
pyridyl complexes, is represented by DNA intercalators. The
versatility of such compounds rely on the possibility to vary
the nature of the substituent group in the intercalative ligand,
modifying the configuration and electron density distribution
of the metal center, allowing to obtain different DNA binding
affinities and photo-cleavage properties. Following this ap-
proach, a considerable number of compounds have been re-
ported, including [Ru(bpy)2(dppz)]
2+ and [Ru(bpy)2(pip)]
2+
(dppz=dipyridophenazine, pip=2-phenylimidazo[4,5-f]
[1,10]phenanthroline), which feature interesting properties as
site-specific luminescent DNA binding agents and abilities to
stall the DNA replication of cancer cells as well.[13,14] However,
some critical disadvantages, such as the short lifetime of triplet
excited state that reduces the 1O2 quantum yield, the low DNA
cleavage activity and the poor solubility in physiological
media, may represent a serious limit for their further develop-
ment as PSs in clinical trials.[15] In this context, Ru-polypyridyl
complexes featuring charged polyamino chains appended to
the heteroaromatic units represent an appealing choice, al-
though, to the best of our knowledge, they have not been
largely investigated as PDT photosensitizer.[16–18]
In this context, we report on two novel ruthenium(II) poly-
pyridyl complexes, [Ru(phen)2L’] and [Ru(phen)2Cu(II)L’] (L and
L-CuII), containing the peculiar polyamine macrocyclic unit
L’(L’=4,4’-(2,5,8,11,14-pentaaza[15])-2,2’-bipyridilophane) (see
Scheme 1). The presence of five amino groups on L’, which
can easily undergo protonation in water, confers to RuII com-
pounds interesting chemical-physical properties, including
high water solubilities. Following the quantitative assessment
of 1O2 produced by light-activation, the ability of these com-
pounds to interact with calf-thymus DNA was investigated, to-
gether with their capacity to damage DNA plasmid as conse-
quence of light-irradiation.
Cellular internalization processes of L and L-CuII were stud-
ied on an A375 human melanoma cell line through confocal
microscopy measurements, by exploiting the classical lumines-
cence of RuII polypyridyl complexes.
Finally, a comparison of their photo-induced biological activ-
ities on a A375 cells was also performed.
Results and Discussion
Synthesis
L and L-CuII were obtained as described in the experimental
following the synthetic strategy shown in Scheme 1. The inter-
mediate (phen)2RuCl2 was prepared accordingly with the meth-
ods described in literature,[19, 20] by reaction of RuCl3·xH2O with
two equivalents of 1,10-phenanthroline in the presence of an
excess of LiCl in anhydrous DMF. The following step consisted
in the direct reaction of (phen)2RuCl2 with the bidentate L’
ligand in ethylene glycol, under microwave irradiation. With re-
spect to conventional heating methods, the use of the micro-
wave assisted technology permits to improve the yield of the
compound and effectively reduces the reaction time.[21, 22] In
our case in fact, L was formed after heating the reaction mix-
ture at 160 8C for only 7 minutes. We can assume that this pro-
cess is also facilitated by the lability of the two chloride li-
gands, which allows their replacement by the bidentate ligand
L’.
Finally, treatment of L with an equimolar amount of
Cu(ClO4)2 at pH 6.5 afforded to obtain the correspondent L-Cu
II
complex directly from the aqueous solution.
Protonation and metal-ion binding properties of L
As previously mentioned, the polyamine chain L’ in L, can
easily protonate in aqueous solution affording highly charged
polyamminum cations and thus making fundamental the pre-
liminary study of the protonation equilibria of L. To this aim,
we started studying the protonation characteristics of that
compound by means of potentiometric measurements in NaCl
0.1m at 2980.1 K. The resulting protonation constants, to-
gether with the distribution diagram of the species present in
solution are reported in Table 1 and Figure S1 (Supporting In-
formation).
The compound acts as a pentaprotic base, with the [H3L]
species being the most abundant at neutral pH values. The
protonation constants appear to be similar to those previously
found for the analogous bipyridyl compound [(bpy)2RuL’]
2+
,
[23]
and consistent with the foreseen protonation pattern for ali-
phatic polyamine macrocycles.[24] However, L displays a lower
basicity, in each protonation step, with respect to the free
macrocyclic unit L’, likely due to the electrostatic repulsion be-
Scheme 1. Synthetic routes for preparation of L and L-CuII complexes.
Table 1. Protonation constants of L determined by means of potentio-
metric measurements in NaCl 0.1m, at 298.10.1 K.
Reaction logK[a]
L2++H+=HL3+ 8.90 (5)
HL3++H+=H2L
4+ 8.01 (6)
H2L
4+
+H+=H3L
5+ 5.32 (5)
H3L
5+
+H+=H4L
6+ 3.93 (5)
H4L
6+
+H+=H5L
7+ 2.44 (6)
[a] Values in parentheses are standard deviations in the last significant
figure. ([L]=110ÿ3m).
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tween the RuII center and the positively charged polyammo-
nium residues.
A further investigation of the proton binding ability of L was
carried out by means of spectrophotometric and spectrofluori-
metric measurements. The UV/Vis spectra of the ruthenium
complex recorded in aqueous media at different pH values are
reported in Figure S2 (Supporting Information). The absorption
spectra display a broad band at about 450 nm, which can be
attributed to a metal-to-ligand dp–p* charge transfer (MLCT)
and a structured band centered at lower wavelengths
(270 nm), due to the ligand centered p–p* transitions of the
phenanthroline units. As shown in Figure S2, the absorption
properties of the compound do not change significantly with
pH, denoting a scarce influence of the protonation state of the
polyamine moiety on its absorption features.[25]
Conversely, the fluorescence emission of L is markedly af-
fected by pH. In fact, as reported in Figure 1, a marked
quenching of the emission is observed as the pH decrease
from 11 to 2.5, together with a red shift of the emission band,
which is 25 nm red-shifted at pH 2 with respect to pH 12.
Analogously to that reported for similar polyammonium
scaffolds,[26] this effect could be rationalized with the increase
in the protonation state of the, polyamino-macrocycle residue
on lowering the pH. The consequent formation of a more dis-
torted excited-state geometry of the molecule, which favors ra-
diationless processes might be responsible for the poor emis-
sive species revealed for low pH values.
Furthermore, a higher protonation state of the receptor unit
might also lead to the formation of a better electron acceptor,
lowering the energy of the MLCT and thus justifying the in-
crease in the Stokes shift observed.
The presence of a polyamine framework directly linked to
the complexed RuII center, confers to L the capacity to act as
binding site for metal ions.[27–29] For that reason we investigat-
ed the binding capacity of L towards ZnII and CuII in aqueous
media, by means of potentiometric titrations. The resulting sta-
bility constants are listed in Table 2, while the distribution dia-
grams of the species present in solution are reported in Fig-
ures S3–S5 (in the Supporting Information). From these data
emerges that L displays a high tendency to form stable mono-
nuclear complexes with both ZnII and CuII in a wide range of
pH (2.5–11).
Furthermore, in the case of CuII, the formation of binuclear
complexes was observed, as also indicated by fluorescence
measurements on solutions of L in the presence of increasing
CuII amounts at neutral pH (Figure S8b in the Supporting Infor-
mation).
In fact, addition of CuII induces an almost linear decrease of
the fluorescence emission of L up to 1 equiv of metal ion. Fur-
ther addition of CuII causes a smoother change of the slope.
The emission intensity decreases up to a 1:2 ligand to metal
molar ratio to achieve a constant value when more than
2 equiv of CuII have been added, thus confirming the forma-
tion in solution of the species with 1:2 stoichiometry, evi-
denced by potentiometric data.
The stability constants determined for the complexation of L
with ZnII and CuII are slightly lower relative to those reported
for the free macrocycle L’.[30] As expected in fact, L’ displays a
reduced coordination ability towards metal ions when its bi-
pyridyl moiety is linked to RuII, due to the electrostatic repul-
sion between the ruthenium center and the positively charged
guest ion.
The UV/Vis absorption spectra of L does not significantly
change upon CuII binding (Figure S6 in the Supporting Infor-
mation). Conversely, the luminescence emission spectra are
strongly affected by CuII binding (see Figure S8). CuII complexa-
tion, in fact, induces a remarkable quenching of the emission,
as expected considering the paramagnetic nature of this metal
anion.[31] In case of ZnII binding instead, both the UV/Vis and
fluorescence emission spectra are only slightly affected by the
metal coordination, with the emission being only 15% de-
creased in the presence of 1 equiv of the metal (Figures S6–
S7).
We point out that, due to the high stability constant of L
with CuII (logK=15.12), in all the following studies the uncom-
plexed copper amount is less than 0.026% with respect to the
copper(II) complexed species. In our experiments all the calcu-
lated pCu values (see Table S1 in the Supporting Information)
are higher than 8.33 (pH 7.2, [L] [L-CuII]=110ÿ4m).
Figure 1. a) Emission spectra of L at different pH values. b) Variation of the
fluorescence emission at 602 nm as a function of pH, overlapped with the
distribution diagram of the protonated species present in solution.
[L]=110ÿ6m, lexc=411 nm.
Table 2. Table Complexation constants of L with ZnII and CuII determined
by means of potentiometric measurements in NaCl 0.1m, at 298.10.1 K.
Reaction logK[a] ZnII logK[a] CuII
L2++M2+=ML4+ 8.09 (8) 15.12 (6)
ML4++H+= [HML]5+ 7.17 (6) 5.63 (7)
[HML]5++H+= [H2ML]
6+ 5.56 (8) 3.94 (7)
[H2ML]
6+
+H+= [H3ML]
7+ 4.75 (8)
ML4++OHÿ= [ML(OH)]3+ 6.12 (9)
ML4++2OHÿ= [ML(OH)2]
2+ 11.55 (9)
L2++2 m2++OHÿ= [M2L(OH)]
5+ 12.71 (8)
[a] Values in parentheses are standard deviations in the last significant
Figure. ([L]=110ÿ3m).
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Interaction of RuII complexes with DNA
Electronic absorption spectroscopy represents a useful tech-
nique to probe the DNA interaction of metal-complexes. In
fact, while base binding is generally associated to a perturba-
tion of the ligand field transition of the metal complex, the in-
tercalative mode of interaction usually determines hypochrom-
ism and batochromism in the MLCT band, with the extent of
hypochromism directly linked to the intercalative binding
strength. In addition, are also possible partial intercalative or
electrostatic modes of interaction, that result in either hyper-
chromism or hypochromism.[32,33]
The interaction of L and L-CuII with calf thymus DNA (ct-
DNA) was studied by monitoring the changes of their absorp-
tion spectra in Tris-HCl buffer at 298 K, upon addition of in-
creasing amounts of the biopolymer to solutions of complexes
at fixed concentration. As shown in Figure 2a, addition of ct-
DNA to a solution of L induces the hypochromism at the MLCT
band of the complex, whose absorbance at 452 nm is reduced
of about 35%, in the presence of 200 mm of ct-DNA.
Similar results were also observed in the case of L-CuII (Fig-
ure S9), although the extent of hypochromism was less intense
with respect to L (ca. 21% at 452 nm, 200 mm of DNA). In both
cases, no blue or red shift was observed upon DNA addition.
To further study the affinity of these complexes with the bio-
polymer, the relative intrinsic binding constants Kb towards ct-
DNA were determined, as described in the Supporting Informa-
tion. Kb values for L and L-Cu
II with ct-DNA were found to be
(2.770.07)104mÿ1 and (1.470.01)104mÿ1 respectively,
while the correspondent plots of [DNA]/(eaÿef) versus [DNA]
are reported in Figure 2b.
Of note, the reckoned constants are slightly higher with re-
spect to that of the parent compound [Ru(phen)3]
2+(<103mÿ1
in the same buffered media),[34,35] which has been reported to
interact with ct-DNA mainly via non-classical intercalation pro-
cesses, namely semi-intercalation, quasi-intercalation and exter-
nal electrostatic binding mode in the major groove of the bio-
polymer.[36,37] We also point out that, these values are ca. 2
order of magnitude lower than those reported for classical
ruthenium based intercalators, such as [Ru(phen)2(dppz)]
2+
,[38,39] thus indicating that a pure intercalative binding of DNA
can be ruled out. Interestingly, the intrinsic binding constant
obtained for L-CuII results to be almost 2-fold lower with re-
spect to that of L, as also shown by the intercept values of the
plot of [DNA]/(eaÿef) versus [DNA] (Figure 2b). A possible ra-
tionalization of that finding could rely on the central role of
the polyamine chain L’ in the interaction with DNA. In particu-
lar, we can speculate that positively charged ammonium
groups on L’ could interact with the phosphate groups of the
biopolymer via electrostatic and hydrogen bonding interac-
tions, justifying the greater Kb value of L relative to that of clas-
sical parent compounds, such as [Ru(phen)3]
2+ .
On the other hand, when a copper ion is bound within the
macrocyclic cavity, the nitrogen donor atoms would be less
available for electrostatic interaction with phosphate back-
bone, resulting in a lowering of Kb.
Analogues titration experiments with DNA were also carried
out by means of fluorescence measurements; unfortunately,
the scarce fluorescence emission of l-CuII prevented the same
analysis on that complex (Figure S10 in the Supporting Infor-
mation). These data highlighted the enhancement of the fluo-
rescence emission of the system with increasing biopolymer
concentrations ([DNA]/[Ru] ratio >1), an effect that is generally
related to the restriction of the mobility of L to the DNA bind-
ing site, which lowers the sensitivity to emission-quenching
processes by collision with solvent molecules.[40] The DNA in-
teraction of L was further investigated by means of steady-
state emission quenching experiments using ferrocyanide
([Fe(CN)6]
4ÿ) as anionic quencher (Q).
Figure 3 shows the Stern–Volmer plot reckoned for the lumi-
nescence quenching of the compound alone and bound to ct-
DNA ([DNA]/[Ru]=20), in the presence of increasing concentra-
tion of ferrocyanide. As shown in Figure, in the absence of
DNA, L is efficiently quenched by ferrocyanide and features a
linear Stern Volmer plot, as expected for a single component
donor-quencher system. In particular, from the slope of the
plot of Fo/F versus [Q], and by applying the linear equation de-
scribed in the experimental, a Ksv value of (11.550.06)
104mÿ1 was obtained, in good agreement with Ksv values re-
Figure 2. a) Absorption spectra of L in Tris-buffer 10 mm, (NaCl 50 mm,
pH 7.2) in presence of increasing amounts of calf thymus DNA. The inset
shows the absorbance at 542 nm as a function of the DNA concentration.
b) Plots of [DNA]/(eaÿef) versus [DNA] obtained from UV titration of L and L-
CuII with ct-DNA. ([L]= [L-CuII]=11 mm, [ct-DNA]=0–220 mm).
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ported for mechanisms of quenching generally attributed to
electrostatic interactions with the quencher molecule.[41]
When DNA is added, the quenching of ligand fluorescence
emission due to addition of ferrocyanide anions is drastically
reduced, evidencing a high affinity between L and DNA. Inter-
estingly, and contrary to the system in the absence of the bio-
polimer, a biphasic Stern–Volmer plot featuring a downward
curvature was obtained (see inset of Figure 3). By the analysis
of these data with equation 3 (in the Supporting Information),
accordingly to the approach followed by Eftink and Selvidge,[42]
we obtained the correspondent parameters, reported in
(Table S2).
The strong decrease of Ksv value from (11.550.06)10
4
m
ÿ1
to (2.600.13)103mÿ1 in the presence of DNA, once again
confirms the effective shielding of L from the quencher mole-
cules, due to the electrostatic repulsion between the polyan-
ionic backbone of DNA and the highly negatively charged
ferro-cyanide anions. On the other hand, the downward curva-
ture observed in the presence of DNA may be explained by
considering the presence in solution of two distinct popula-
tions of RuII complexes, featuring different chemical surround-
ings.[36,42,43]
With the aim of going deeper into this topic, excited state
lifetimes measurements of L in absence and in presence of ct-
DNA at a ratio [L]/[DNA] of 1:20, were performed. The reck-
oned fluorescence decay times are reported in Table 3, while
the correspondent emission decay profiles as a function of
time are shown in Figure S11 (in the Supporting Information).
In absence of DNA, the fluorescence decay curve fits well
with a mono-exponential decay functional form, resulting in a
lifetime of t1=375.81.4 ns with a R2=0.99879.
Upon binding of ct-DNA, the complex exhibits a bi-exponen-
tial decay, featuring two distinct fluorescence decay times, t1=
73.71.3 ns and t2=606.33.3 ns, with a R2=0.99965. The
origin of a bi-exponential decay curve, characterized by two
fluorescence lifetimes, would confirm the presence of two
DNA bound ruthenium species, featuring different solvent ac-
cessibilities. With this respect, the polynucleotide reasonably
provides a hydrophobic cavity to the ruthenium compound
preventing its luminescence quenching by water molecules.
We can speculate that this process would involve the partial
insertion of a phenantroline unit into the major/minor groove
of DNA,[44] justifying the longer lifetime component of the lu-
minescence decay. On the other hand, the shorter lifetime
component may be attributed to electrostatic/hydrogen bond-
ing interactions between the positively charged polyammo-
nium chain of L and the negative charged phosphate groups
on the DNA backbone, making the RuII center more exposed
to solvent molecules.[45, 46]
Moreover, the longer lifetime found in the presence of the
biopolymer is almost 30% lower than that reported for classi-
cal intercalating RuII complexes, such as [Ru(phen)2dppz]
2+ (ca.
800 ns),[47] ruling out a pure intercalative interaction mode, in
agreement with the spectroscopic and fluorescence titrations
discussed above.
Singlet oxygen production
Preliminary to the evaluation of the light-induced damage of
RuII compounds towards biological targets, is the quantitative
assessment of the singlet oxygen 1O2 produced by these sys-
tems upon irradiation.
To this aim, the phosphorescence signals of 1O2 at 1270 nm
induced by irradiation of compounds at 400 nm in air-saturat-
ed CH3CN solutions were measured. The correspondent
1O2
quantum yields (fD) were evaluated by comparison with the
reference molecule tetraphenylporphyrin (TPP), as described in
the experimental section. The resulting values are reported in
Table 3. As shown, the 1O2 quantum yield (fD) determined for
L was found to be 0.290.06. This value is comparable with
that measured for the parental compound Ru(phen)3
2+ under
the same experimental conditions (fD=0.380.06), thus indi-
cating that the substitution of a phenantroline unit with the
bipyridyl chelating moiety of L’ does not significantly affect
the capacity of the complex to produce 1O2.
On the contrary, in case of L-CuII no 1O2 emission was detect-
ed under these experimental conditions. Quenching of the
fluorescence emission of the MLCT state of L in presence of
CuII together with the lack of evidence for 1O2 production, can
be explained by supposing that the decay of the MLCT state of
L-CuII occurs mainly through internal conversion and likely on
a faster timescale with respect to L.
Figure 3. Ster-Volmer plots for the quenching of fluorescence of free (black
squares) and DNA-bound (red circles) complex L with [Fe(CN)6]
4ÿ. On top
left of the Figure is shown a magnification of the Stern–Volmer plot for L-
DNA system. [L]=3 mm, [DNA]/[Ru]=40, lexc=411 nm, lem=634 nm.
Table 3. Excited state life-time values obtained by fluorescence measure-
ments together with the 1O2 quantum yields (fD) determined in air-satu-
rated CH3CN solutions.
Reaction t1 [ns] t2 [ns] t1:t2 fD
Free L 375.81.4 0.290.06
L/DNA 73.71.3 606.33.3 29:71
Ru(phen)3
2+ 0.380.08
Chem. Eur. J. 2019, 25, 1 – 11 www.chemeurj.org  2019 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim5 &&
These are not the final page numbers! ÞÞ
Full Paper
DNA cleavage activity
The potential of L and L-CuII to induce a damage on biological
targets was investigated by means of gel electrophoresis ex-
periments on DNA plasmid. This technique permits in fact to
distinguish the different conformational states of the biopoly-
mer upon drug-interaction, based on its relative mobility on
the gel. In particular the DNA plasmid, which is naturally occur-
ring as a covalently closed circular or “supercoiled” form (form
I, ~2000 bp) and as an open circular form (~4000 bp), can be
cleaved on one strand leading to the formation of a relaxed/
nicked conformation (form II), that migrates approximately as
the open circular form.
In addition, more severe damages on DNA can provoke the
cleavage of both strands of the biopolymer, leading to the for-
mation of the linear form of DNA (form III), at ~3000 bp.
We first studied the ability of L to damage the DNA plasmid
upon light-activation, by dosing plasmid puC19 with increasing
RuII concentrations (0–100 mm) and analyzing the samples
under dark and following irradiation (Figure 4).
As shown, no DNA cleavage occurs when the complex is
kept under dark conditions. In fact, neither the supercoiled nor
the open circular form of DNA undergo significant variations in
the presence of the ruthenium compound, for the overall
range of concentration tested. Following photo-activation, a
progressive conversion of the supercoiled form of DNA (form I)
to the relaxed/nicked form (form II) was observed with increas-
ing RuII concentrations, denoting a dose-dependent DNA
cleavage activity in the formation of single strand breaks (SSBs)
on the plasmid.[48,49] This would be reasonably associated to
the ability of L to produce singlet oxygen when light-activated,
as discussed above.
An analogues study was performed on L-CuII and results are
reported in Figure (Figure 5a,b). Under dark conditions, L-CuII
does not alter the natural conformations of DNA, at least in a
range of RuII concentrations within 0–25 mm. For higher ruthe-
nium concentrations, a conversion of the form I into form II
was observed, indicating a nuclease activity of the copper
complex itself.[50] Following irradiation, a stronger oxidative
damage on DNA was obtained, as revealed by the progressive
conversion of form I to form II accompanied by the formation
of the linear conformation of plasmid with increasing RuII con-
centrations. This indicates the occurrence of double strand
breaks (DSBs) on plasmid, more difficult to repair by restriction
enzymes with respect to those provoked by SSBs,[51] in contrast
with that obtained for L.
Besides the photo-activated experiments, we also evaluated
the ability of L-CuII to promote an oxidative damage on DNA
under dark conditions, exploiting the presence of the Fenton
active metal center CuII. To this aim, solutions of puC19 con-
taining increasing concentrations of L-CuII (0–100 mm) were an-
alyzed in the presence of a fixed concentration of hydrogen
peroxide as co-reactant (Figure 5c). As shown, a progressive
conversion of the supercoiled form to the relaxed/nicked con-
formation, together with the formation of the linear form III,
was observed with increasing concentration of compound. The
effect was greater with respect to that obtained in case of
light activation of the compound. In particular, above 12.5 mm
of compound, form I undergoes an almost complete conver-
sion to form II and form III, comparable to that obtained for
the simultaneous presence of CuII ion and H2O2 (control
sample, lane 2 Figure 5b). This clearly evidences a straightened
capacity of L-CuII to produce both single and double strand
breaks on DNA in presence of H2O2. With this regard, we can
speculate that the copper ion would be involved into Fenton
or Fenton-like reactions with hydrogen peroxide (namely CuII+
H2O2!Cu
I
+OHÿ+ COH).
The involvement of the CuII ion of L-CuII in Fenton like redox
cycles when treated with the co-reactant was also suggested
by the monitoring the absorbance at the d–d band of CuII in
presence of increasing H2O2 concentrations, by means of spec-
trophotometric measurements (Figure S12–S13, in the Sup-
porting Information).
In vitro studies
Our further step in the investigation of the effective potential
of L and L-CuII to being used as possible drugs for PDT applica-
tions, was represented by the study of their cellular interaction.
To this aim, we focused on the ability of RuII compounds to in-
teract with an A375 human melanoma cell line, by means of
Confocal Laser Scanning Microscopy (CLSM) exploiting the
Figure 4. Agarose gels showing the dose response of L with 40 mgmLÿ1
puC19 plasmid before (a) and after (b) 15 minutes of irradiation with visible
light (l>450 nm, 200 W). Lanes 1 and 11, DNA molecular weight standard;
lane 2, plasmid treated with EcoRI restrictase as control for linear DNA; lanes
3–10, 0, 1.56, 3.12, 6.25, 12.5, 25, 50, 100, mm of L.
Figure 5. Agarose gels showing the dose response of L-CuII with 40 mgmLÿ1
puC19 plasmid before (a) and after (b) 15 minutes of irradiation with visible
light (l>450 nm, 200 W). Lanes 1 and 11, DNA molecular weight standard;
lane 2, plasmid treated with EcoRI restrictase as control for linear DNA; lanes
3–10, 0, 1.56, 3.12, 6.25, 12.5, 25, 50, 100 mm of L-CuII. c) Agarose gel electro-
phoresis of L-CuII with 40 mgmLÿ1 pUC19 in presence of H2O2 (50 mm). Lanes
1 and 12, DNA molecular weight standard; lane 2, linear puC19; lane 3, plas-
mid treated with CuII and H2O2 (100 mm each) and lanes 4–11, 0, 1.56, 3.12,
6.25, 12.5, 25, 50, 100 mm of l-CuII complex.
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classical luminescence of RuII complexes with polypyridine.
Some representative CLSM images collected by incubating
A375 cells with L and L-CuII, as described in the experimental,
are reported in Figure 6. As shown, cells treated with L and L-
CuII display several fluorescent spots into their cytoplasm and,
in a less extent, inside the nuclei. This evidence clearly indi-
cates that both compounds feature a great ability to being in-
ternalized into the cellular compartments. Nevertheless, to
date a comparison between the relative cellular penetration
capacities is not completely reliable due to the scarce fluores-
cence emission of the copper complex with respect to L (Fig-
ure S8, in the Supporting Information). Of note, the ruthenium
compounds appear to being not randomly distributed into the
cellular cytosol but rather finely localized around the outer
membrane of the nuclei. Despite further studies will be carried
out to define the mechanism of internalization of both L and
L-CuII, this finding let us to speculate that the cellular uptake
of such compounds would be ruled by specific endocytosis
phenomena,[52] as discussed by Poynton et al.[53] in the case of
analogues RuII polypyridyl complexes.
Before evaluating the light-induced cytotoxic potential of L
and L-CuII, we analyzed the effect of both compounds in the
1–100 mm range of concentration, on A375 cell viability
through MTT assay. As shown in Figure S15, L appears to be
no toxic, as demonstrated by the fact that the higher dose
causes only a 12% reduction of cell viability. Conversely, L-CuII
results very cytotoxic, featuring a IC50 value of about 40 mm.
As a consequence, to better discriminate the light-induced ef-
fectiveness of compounds, a narrower range of concentration
was chosen (up to 5 mm). In fact, in this range the compounds
are no cytotoxic when not irradiated. In Figure 7 are reported
the viability titres of A375 cells treated with different concen-
trations of L and L-CuII respectively, measured before (black
bars) and upon (grey bars) irradiation through MTT assay. As
shown, the viability of cells not exposed to light is comparable
to that of controls, for both the compounds, thus confirming
that L and L-CuII are no toxic under dark conditions, being well
tolerated by cells. Following photo-activation (grey bars in
Figure), we observed a different behavior for L and L-CuII. In
particular, despite the capacity to produce 1O2 upon light-acti-
vation, L results to be effective in reducing the cell viability
only for doses higher than 5 mm.
Of note, a greater photo-induced cytotoxicity was observed
for L-CuII, which is effective even at lower concentrations
(0.25 mm) and features a dose-dependent activity. This finding
can be rationalized considering the key role of the copper(II)
ion within the macrocyclic cavity L’.
Based on these data in fact, we can speculate that the
Fenton-active copper center plays a synergetic role with light
activation in the development of cytotoxic ROS species, pro-
viding additional mechanisms for the oxidative damage to bio-
logical targets.
Conclusions
In summary, we report on the synthesis and chemical physical
characterization of two novel RuII and RuII/CuII polypyridyl com-
plexes containing the peculiar polyamino-macrocycle unit L’.
The presence of easily protonatable amine groups within
the macrocyclic moiety not only confers to RuII compounds
high solubilities in water but also appears to strongly influence
their interaction with calf-thymus DNA.
Moreover, L and L-CuII exhibit market light-induced cleavage
activities on DNA plasmid, based on different mechanisms of
action. In particular, while L leads to single strand breaks (SSBs)
Figure 6. Fluorescence confocal microscopy imaging of A375 human mela-
noma cells incubated with L and L-CuII (5 mm each) for 24 hours. A and B
show different magnifications of the images. DAPI (200 Nm, lex 358 nm, lem
461 nm) was used to stain nuclei (blue spots) while in green is showed the
fluorescence emission of L and L-CuII respectively (lexc 440–480 nm, lem 600–
640 nm).
Figure 7. Cell viability assays of A375 human melanoma cells treated with in-
creasing concentrations of L (a) and L-CuII (b) measured before (black bars)
and upon light irradiation (grey bars). Tests were carried out in quadrupli-
cate. All data were normalized with respect to control tests. Data reported
in the Figure represent the mean value  S.E.M.
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on puC-19 plasmid upon light activation, likely due to its ca-
pacity to produce singlet oxygen when irradiated, L-CuII deter-
mines the formation of more severe double strand breaks
(DSBs), suggesting the generation of ROS as consequence of
Fenton like reactions involving the copper ion.
Thanks to the classical luminescence of RuII polypyridyl com-
plexes, it was also possible to monitor the cellular internaliza-
tion processes of RuII compounds by means of confocal mi-
croscopy technique. Of note, L and L-CuII display high tenden-
cies to being internalized into an A375 human melanoma cell
line, with the ruthenium compounds finely placed around the
outer membrane of the nuclei.
Finally, a comparative study of the biological activity of the
ruthenium complexes on A375 cells confirmed that both L and
L-CuII are no-toxic under dark conditions but display an en-
hanced cytotoxicity when exposed to light. In particular, L-CuII
shows a greater photo-induced dose-dependent cytotoxicity
with respect to L, highlighting the key role of the CuII metal
center coordinated within the L’ moiety, in the biological activ-
ity of such typology of compounds.
Despite further studies need to be performed in order to
deeply characterize the oxidative pathways originated from
photo-activation of L-CuII, these results suggest that the
Fenton-active copper center plays a synergetic role with light
activation in the development of ROS species, thus providing
additional/alternative mechanisms for the oxidative damage of
biological targets relative to the sole singlet oxygen produc-
tion.
In conclusion, from our studies emerges that an appropriate
design of RuII polypyridyl complexes containing specific poly-
amine frameworks for CuII-binding could represent a promising
tool for the development of novel and effective PSs in photo-
dynamic therapy.
Experimental Section
Synthesis
All materials were of reagent grade and used without further pu-
rification. The synthesis of 4,4’-(2,5,8,11,14-pentaaza[15])-2,2’-bipyri-
dilophane (L’) was described in a previous paper.[30]
Calf thymus DNA (ct-DNA) was purchased from Sigma Aldrich as
sodium salt. Solutions of ct-DNA were obtained by dissolving it in
Tris-HCl buffer (5 mm Tris-HCl, 50 mm NaCl, pH 7.2). The purity of
DNA was assessed by UV absorption measurements; a UV absorb-
ance ratio at 260 and 280 nm of about 1.8–1.9:1, indicates that
DNA was sufficiently free of protein.[54] The DNA concentration per
nucleotide was determined by absorption spectroscopy using the
molar absorption coefficient 6600mÿ1 cmÿ1 at 260 nm.[55]
Synthesis of [Ru(phen)2L’]Cl2 (L): Equimolar amounts of Ru(-
phen)2Cl2 and L’ (0.24 mmol) were suspended in 9.6 mL of ethylene
glycol. After sonication to facilitate the dispersion of reagents into
the solvent, the mixture was heated in a microwave reactor
(300 W) for 7 minutes at 160 8C. The dark-violet suspension
became a deep orange solution. After being cooled at room tem-
perature, the solvent was removed by distillation at low pressure,
and the residue was dissolved in the minimal amount of HCl 6m.
Water was completely removed by evaporating the solution under
reduced pressure. Ethanol was added and the resulting red-orange
suspension was collected by filtration and washed with acetone/
ethyl ether. The product, obtained as penta-hydrochloride salt, was
recrystallized twice from ethanol, washed with ethyl ether and
dried on H2SO4 97%. Anal. Found: C, 47.3; H, 5.1; N, 13.7. Calcd. for
C44H56Cl7N11RuO2 : C, 47.18; H, 5.04; N, 13.75.
1H NMR (D2O + DCl,
pD <2, 400 MHz, Bruker ARX-400): d=8.91 (s, 2H, L’, 3,3’) ; 8.66 (d,
2H, L’, 6, 6’) ; 8.53 (d, 2H); 8.28 (d, 2H); 8.21 (m, 4H); 7.91 (d, 2H,
L’, 5,5’) ; 7.85 (d, 2H); 7.79 (m, 2H); 7.52 (m, 2H); 7.31 (d, 2H); 4.59
(m, 4H, L’, pyCH2N); 3.65 ppm (m, 16H, L’, NCH2CH2N).
13C NMR
(D2O, pD <2, 400 MHz, Bruker ARX-400): d=152.5, 152.3, 151.8,
148.3, 147.6, 146.9, 137.0, 136.8, 133.7, 130.9, 127.8, 127.49, 127.1,
126.7, 125.9, 125.3, 123.1, 53.7, 47.9, 45.3, 44.9, 44.6 ppm. ESI-MS:
[M+] m/z=831.3; [M2+] m/z=415.65. Yield: 234.4 mg, 0.18 mmol
(75%).
Synthesis of [CuRu(phen)2L’](ClO4)4·4H2O : A 10 mL of aqueous so-
lution of Cu(ClO4)2·6H2O (7.50 mg, 0.020 mmol) was added to a so-
lution of LCl2·5HCl·2H2O (22.5 mg, 0.020 mmol) in 25 mL of water.
The pH was adjusted to 6.5 with NaOH 0.1 and NaClO4 (100 mg)
was added. The solution was stirred at room temperature for 1 h.
A blue powder of CuL(ClO4)4·4H2O was formed by slow evapora-
tion. Yield: 23 mg (85%). Elem. Anal. calcd for C44H55N11RuCuCl4O20 :
C, 38.68; H, 4.06; N, 11.28. Found: C, 38.6; H, 4.1; N, 11.2%.
Potentiometric measurements : Equilibrium constants for protona-
tion and metal ion binding of L were determined by means of po-
tentiometric measurements (pH=-log [H+]), carried out in de-
gassed 0.1m NaCl at 298.10.1 K, by using equipment and proce-
dures which have been already described.[56,57]
The reference electrode was an Ag/AgCl electrode in saturated KCl
solution. The glass electrode was calibrated as a hydrogen concen-
tration probe by titrating known amounts of HCl with CO2-free
NaOH solutions and the equivalent point was determined by using
the Gran’s method.[58] Through this process we determined the
standard potential Eo, as well as the ionic product of water (pKw=
13.730.01 at 298.1 K in 0.1m NaCl). Three titration experiments
(consisting of 100 data points for each one) were performed in the
pH range 1.5–12.
A ligand concentration of about 110ÿ3m was generally em-
ployed. In ZnII titrations a metal ion concentration of 0.8[L] was
used while in the case of CuII its concentration varied from 0.8[L]
to 1.8[L] . The computer program HYPERQUAD[59] was used to de-
termine both protonation and complexation (metal ions) constants
of the ligand from e.m.f. data.
Electronic absorption and fluorescence measurements : Absorp-
tion spectra were registered on a PerkinElmer Lambda 6 spectro-
photometer. Fluorescence spectra were recorded on a PerkinElmer
LS55 spectrofluorimeter, by using an excitation wavelength of
411 nm. All measurements were performed at 298.00.1 K by
using solutions of ligand in Tris-HCl buffer (5 mm, NaCl 50 mm,
pH 7.2). Absorption and fluorescence titration of RuII complexes-
with ct-DNA were carried out and data analyzed as described in
details in the supporting information.
Excited state lifetime measurements : Excited state lifetime meas-
urements were perfomed by using a 50 mm solution of L in Tris-HCl
Buffer (pH 7.2), in a fused silica 10 mm path length cuvette. Meas-
urements were carried out in backscattering geometry, where the
532 nm radiation, corresponding to the second harmonic of a
Nd:YAG pulsed laser, was focused on the cuvette and the fluores-
cence radiation was collected by a lens and focalized on the slit of
a monochromator (Princeton Instruments Acton 2300i) passing
through a notch filter to suppress the backscattered laser radiation.
The dispersed fluorescence spectra were detected by an air-cooled
CCD. The time variable was introduced using a pulsed detection.
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The CCD detector was activated with a high voltage pulse of 5 ns
time width, starting 20 ns before the laser pulse up to 2280 ns
after, for a total time of 2300 ns. For each sample, 461 fluorescence
spectra were registered and entirely integrated. The fluorescence
decay curves were obtained by reporting in a graph the integrated
intensity values versus the time delay with respect to the laser
pulse.
The same procedure was followed for both the free ruthenium
complex and that containing 20 equivalents of ct-DNA.
The excited state decay profiles for L with DNA were fitted to biex-
ponential decay curves while a single exponential decay fit was ap-
plied in the case of the free ruthenium complex.
Singlet oxygen detection : The emission from 1O2 at 1270 nm in-
duced by laser excitation of the ruthenium-based systems was
used to determine the relative 1O2 quantum yields values (fD) in
CH3CN air-saturated solutions. In all the experiments the laser
source was a Ti-Sapphire ultrafast laser delivering 100 fs long
pulses at 82 MHz repetition rate and 800 nm wavelength. The laser
pulse was frequency doubled at 400 nm to excite the solutions.
Tetraphenylporphyrin (TPP) was chosen as reference standard
while Ru(phen)3 was included in our experiments in order to com-
pare the 1O2 quantum yields of L and L-Cu
II with a parental com-
pound featuring analogue chemical makeup of the ruthenium
center. All samples were dissolved in acetonitrile and held in 1 cm
path quartz cuvettes. Samples were saturated with air and no O2
was insufflated in the solutions. 1O2 emission was collected by a
lens set at 908 with respect to the 400 nm exciting laser beam and
focused on a N2 cooled InGaAs photodiode. To select
1O2 emission
an interference filter centered at 127020 nm was placed in front
of the photodiodie. A chopper working at 90 Hz was placed on the
exciting beam and used to trigger a lock-in amplifier, which singled
out and averaged the signal from the photodiode. In order to
verify that only singlet oxygen emission was measured by the ex-
perimental set-up all the sample solutions were degassed through
pump-freeze-thow cycles in quartz tubes sealed under vacuum
and no signal from these samples was observed. Experiments were
run on solutions of different concentration with absorbance values
at 400 nm in the range 0.08–0.2 and with increasing applied laser
power. Linearity with respect to applied laser power was observed.
The 1O2 quantum yields of samples (S) were calculated with the
formula:
D Sð Þ ¼ D Rð Þ
s Sð Þx 1ÿ 10ÿA Rð Þ
 
s Rð Þx 1ÿ 10ÿA Sð Þ½ 
ð1Þ
where fD (S) and fD (R) represents the
1O2 quantum yields of sam-
ples and the reference, respectively, s is the slope of the linear plot
of the intensity of 1O2 luminescence signal as a function of the in-
tensity of the exciting laser, and A(R/S) represents the absorbance
at 400 nm for the R/S solutions. A fD value of 0.60 was used for
TPP, as reported by R. Schmidt and E. Afshari by chemical methods
in acetonitrile.[60]
Gel electrophoresis experiments : The ability of RuII compounds
to damage DNA, was tested by using the puC-19 plasmid. The
DNA forms were resolved on 1% agarose gel in Tris-Acetate-EDTA
buffer (TAE, pH 8). Experiments were performed by dosing the
plasmid with increasing concentrations of RuII compounds. Typical-
ly, each sample was prepared by adding 10 mL of a concentrated
solution of the ruthenium compounds (L or L-CuII, pH 7.4), to 10 mL
of puC-19 (80 mgmLÿ1) in order to obtain final concentrations of
ruthenium and pUC-19 of 0–100 mm and 40 mgmLÿ1, respectively,
in a total volume of 20 mL. After mixing, the samples were incubat-
ed at 37 8C for 30 minutes. As markers were used Gene ruler DNA
(1kb) and mass ruler high range DNA ladders, while as control for
double strand breaks, a reference plasmid sample was linearized
with EcoRI endonuclease (Fast digest EcoRI, Fermentas). The inacti-
vation of EcoRI, was obtained by keeping the temperature at 80 8C
for 5 minutes. 6 mL of each sample, 3 mL of milliQ water and 1 mL
of Fast Digest Green Buffer 10X, as DNA loading dye, were mixed
together. The resulting samples were run for 45 minutes at 100 mV
and the gels were finally analyzed with a trans-Uv illuminator.
Photodynamic experiments were performed before and after
15 minutes of irradiation with visible light (l>450 nm) of samples
containing DNA and the ruthenium complexes (L and L-CuII) at in-
creasing molar concentrations. The DNA-cleavage like activity of L-
CuII was instead investigated by performing the experiments in the
absence and in the presence of 50 mm of H2O2, under dark condi-
tions.
Flow cytometry and confocal microscopy : A 375 human melano-
ma cells (1105) were seeded in p35 well and incubated with L
and L-CuII (5 mm) for 24 h. Then cells were extensively washed with
PBS, trypsinized and pelleted by centrifugation in conical 15 mL
tubes. Cells were analysed by a FACS-Canto-II flow cytometer (BD
Biosciences, San Jose, CA, USA) and data were analysed with the
FACSDiva (Ashland, OR, USA) software. For each samples 1104
events were acquired.
For confocal microscopy, cells were plated on glass cover slips and
incubated with L and L-CuII (5 mm) for 24 h. Then they were
washed with PBS and fixed with 3% formaldheyde solution in PBS
for 20 min at room temperature. After extensive washing in PBS,
the cells were permeabilized with 0.1% TritonX100 (Sigma) and
subsequently incubated with DAPI Molecular Probes (200 nm, lexc
358 nm, lem 461 nm) to stain nuclei. The cells were mounted with
glycerol plastine and observed under a laser-scanning confocal mi-
croscope (LeicaSP8).
Cell viability : Cell viability was evaluated by using the MTT
method. Briefly, A375 cells (1104) were seeded on 24 multiplate
well, and the incubated in the presence of increasing compound
concentrations. For each compound (L or L-CuII) two plates were
prepared: the first was used as control test and was maintained in
the dark, while the latter was exposed to light. After 24 hours incu-
bation, cells treated with L and L-CuII were exposed to light for
15 minutes, using a 60 watts light positioned at 4 cm distance
from plate. After radiation, plates were stored for further 48 h at
37 8C. Finally, cell viability was assayed incubating cells in the pres-
ence of 0.5 mgmLÿ1 of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide salt for 1 hour. Then, cells was washed with PBS
and lysed using DMSO solution, to dissolve insoluble formazan
crystals produced by viable cells. The absorbance of solutions ob-
tained was determined by using a microplate readers (Model 550
Microplate Reader, Biorad, USA).
To evaluate the light-induced cytotoxicity of ruthenium com-
pounds, a range of concentration up to 5 mm was chosen. In fact,
as resulted by a preliminary MTT assay (performed in analogues ex-
perimental conditions with respect to those above described), in
this range of concentration both compounds are almost not cyto-
toxic when not irradiated.
Acknowledgements
We thank the MIUR-Italy (“Progetto Dipartimenti di Eccellenza
2018–2022” allocated to Department of Chemistry “Ugo
Schiff”) for economic contribution.
Chem. Eur. J. 2019, 25, 1 – 11 www.chemeurj.org  2019 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim9 &&
These are not the final page numbers! ÞÞ
Full Paper
Conflict of interest
The authors declare no conflict of interest.
Keywords: Photodynamic Therapy · Polypyridyl ligands · ROS ·
Ruthenium(II) complexes
[1] D. E. J. G. J. Dolmans, D. Fukumura, R. K. Jain, Nat. Rev. Cancer 2003, 3,
380–387.
[2] Z. Zhou, J. Song, L. Nie, X. Chen, Chem. Soc. Rev. 2016, 45, 6597–6626.
[3] E. Gianotti, B. M. Estev¼o, F. Cucinotta, N. Hioka, M. Rizzi, F. Renò, L. Mar-
chese, Chem. Eur. J. 2014, 20, 10921–10925.
[4] G. Boccalini, L. Conti, C. Montis, D. Bani, A. Bencini, D. Berti, C. Giorgi, A.
Mengoni, B. Valtancoli, J. Mater. Chem. B 2017, 5, 2788–2797.
[5] J. Hess, H. Huang, A. Kaiser, V. Pierroz, O. Blacque, H. Chao, G. Gasser,
Chem. Eur. J. 2017, 23, 9888–9896.
[6] A. P. Castano, T. N. Demidova, M. R. Hamblin, Photodiagn. Photodyn.
Ther. 2004, 1, 279–293.
[7] C. Mari, V. Pierroz, S. Ferrari, G. Gasser, Chem. Sci. 2015, 6, 2660–2686.
[8] J. T. Dy, K. Ogawa, A. Satake, A. Ishizumi, Y. Kobuke, Chem. Eur. J. 2007,
13, 3491–3500.
[9] L. B. Josefsen, R. W. Boyle, Met. Based Drugs 2008, 2008, 276109.
[10] H. Huang, P. Zhang, H. Chen, L. Ji, H. Chao, Chem. Eur. J. 2015, 21, 715–
725.
[11] M. Jakubaszek, B. Goud, S. Ferrari, G. Gasser, Chem. Commun. 2018, 54,
13040–13059.
[12] J. W. Dobrucki, J. Photochem. Photobiol. B 2001, 65, 136–144.
[13] V. Brabec, J. Kasparkova, Coord. Chem. Rev. 2018, 376, 75–94.
[14] C. Mari, V. Pierroz, R. Rubbiani, M. Patra, J. Hess, B. Spingler, L. Oehning-
er, J. Schur, I. Ott, L. Salassa, Chem. Eur. J. 2014, 20, 14421–14436.
[15] H. J. Yu, S. M. Huang, L. Y. Li, H. N. Jia, H. Chao, Z. W. Mao, J. Z. Liu, L. N.
Ji, J. Inorg. Biochem. 2009, 103, 881–890.
[16] M. Klajner, C. Licona, L. Fetzer, P. Hebraud, G. Mellitzer, M. Pfeffer, S. Har-
lepp, C. Gaiddon, Inorg. Chem. 2014, 53, 5150–5158.
[17] E. V. Bichenkova, X. Yu, P. Bhadra, H. Heissigerova, S. J. A. Pope, B. J. Coe,
S. Faulkner, K. T. Douglas, Inorg. Chem. 2005, 44, 4112–4114.
[18] A. Terenzi, M. Fanelli, G. Ambrosi, S. Amatori, V. Fusi, L. Giorgi, V. T.
Liveri, G. Barone, Dalton Trans. 2012, 41, 4389–4395.
[19] T. E. Keyes, J. G. Vos, J. A. Kolnaar, J. G. Haasnoot, J. Reedijk, R. Hage,
Inorg. Chim. Acta 1996, 245, 237–242.
[20] E. Wachter, D. K. Heidary, B. S. Howerton, S. Parkin, E. C. Glazer, Chem.
Commun. 2012, 48, 9649.
[21] F. A. Beckford, M. Shaloski, G. Leblanc, J. Thessing, L. C. Lewis-Alleyne,
A. A. Holder, L. Li, N. P. Seeram, Dalton Trans. 2009, 48, 10757–10764.
[22] J. Cao, Q. Wu, W. Zheng, L. Li, W. Mei, RSC Adv. 2017, 7, 26625–26632.
[23] C. Lodeiro, F. Pina, A. J. Parola, A. Bencini, A. Bianchi, C. Bazzicalupi, S.
Ciattini, C. Giorgi, A. Masotti, B. Valtancoli, J. S. de Melo, Inorg. Chem.
2001, 40, 6813–6819.
[24] A. Bencini, A. Bianchi, E. Garcia-EspaÇa, M. Micheloni, J. Ramirez, Coord.
Chem. Rev. 1999, 188, 97–156.
[25] Z. Murtaza, Q. Chang, G. Rao, H. Lin, J. R. Lakowicz, Anal. Biochem. 1997,
247, 216–222.
[26] F. Bettazzi, D. Voccia, A. Bencini, C. Giorgi, I. Palchetti, B. Valtancoli, L.
Conti, Eur. J. Inorg. Chem. 2018, 2675–2679.
[27] S. Nistri, G. Boccalini, A. Bencini, M. Becatti, B. Valtancoli, L. Conti, L. Lu-
carini, D. Bani, Free Radical Res. 2015, 49, 67–77.
[28] O. Francesconi, M. Gentili, F. Bartoli, A. Bencini, L. Conti, C. Giorgi, S.
Roelens, Org. Biomol. Chem. 2015, 13, 1860–1868.
[29] M. C. Aragoni, M. Arca, A. Bencini, C. Caltagirone, L. Conti, C. Garau, B.
Valtancoli, F. Isaia, V. Lippolis, F. Palomba, L. Prodi, N. Zaccheroni, Supra-
mol. Chem. 2017, 29, 912–921.
[30] C. Lodeiro, A. J. Parola, F. Pina, C. Bazzicalupi, A. Bencini, A. Bianchi, C.
Giorgi, A. Masotti, B. Valtancoli, Inorg. Chem. 2001, 40, 2968–2975.
[31] A. M. Josceanu, P. Moore, S. C. Rawle, P. Sheldon, S. M. Smith, Inorg.
Chim. Acta 1995, 240, 159–168.
[32] Y. J. Liu, H. Chao, L. F. Tan, Y. X. Yuan, W. Wei, L. N. Ji, J. Inorg. Biochem.
2005, 99, 530–537.
[33] A. Łe˛czkowska, J. Gonzalez-Garcia, C. Perez-Arnaiz, B. Garcia, A. J. P.
White, R. Vilar, Chem. Eur. J. 2018, 24, 11785–11794.
[34] A. M. Pyle, J. P. Rehmann, R. Meshoyrer, C. V. Kumar, N. J. Turro, J. K.
Barton, J. Am. Chem. Soc. 1989, 111, 3051–3058.
[35] P. Lincoln, B. Norden, J. Phys. Chem. B 1998, 102, 9583–9594.
[36] S. Satyanarayana, J. C. Dabrowiak, J. B. Chaires, Biochemistry 1993, 32,
2573–2584.
[37] M. Eriksson, M. Leijon, C. Hiort, B. Norden, A. Graeslund, J. Am. Chem.
Soc. 1992, 114, 4933–4934.
[38] C. Turro, S. H. Bossmann, Y. Jenkins, J. K. Barton, N. J. Turro, J. Am. Chem.
Soc. 1995, 117, 9026–9032.
[39] A. E. Friedman, J. K. Barton, J. C. Chambron, J. P. Sauvage, N. J. Turro, J.
Am. Chem. Soc. 1990, 112, 4960–4962.
[40] J. K. Barton, A. T. Danishefsky, J. M. Goldberg, J. Am. Chem. Soc. 1984,
106, 2172–2176.
[41] D. Wang, J. Wang, D. Moses, G. C. Bazan, A. J. Heeger, Langmuir 2001,
17, 1262–1266.
[42] M. R. Eftink, L. A. Selvidge, Biochemistry 1982, 21, 117–125.
[43] D. E. Schlamadinger, D. I. Kats, J. E. Kim, J. Chem. Educ. 2010, 87(9), 961–
964.
[44] D. Z. M. Coggan, I. S. Haworth, P. J. Bates, A. Robinson, A. Rodger, Inorg.
Chem. 1999, 38, 4486–4497.
[45] J. K. Barton, J. M. Goldberg, C. V. Kumar, N. J. Turro, J. Am. Chem. Soc.
1986, 108, 2081–2088.
[46] S. J. Moon, J. M. Kim, J. Y. Choi, S. K. Kim, J. S. Lee, H. G. Jang, J. Inorg.
Biochem. 2005, 99, 994–1000.
[47] R. E. Holmlin, E. D. A. Stemp, J. K. Barton, Inorg. Chem. 1998, 37, 29–34.
[48] B. S. Howerton, D. K. Heidary, E. C. Glazer, J. Am. Chem. Soc. 2012, 134,
8324–8327.
[49] L.-F. Tan, F. Wang, H. Chao, Helv. Chim. Acta 2007, 90, 205–215.
[50] P. U. Maheswari, S. Roy, H. D. Dulk, S. Barends, G. Van Wezel, B. Kozlev-
cˇar, P. Gamez, J. Reedijk, J. Am. Chem. Soc. 2006, 128, 710–711.
[51] F. V. Pamatong, C. A. Detmer, J. R. Bocarsly, J. Am. Chem. Soc. 1996, 118,
5339–5345.
[52] P. E. C. Filho, M. P. Cabrera, A. L. C. Cardoso, O. A. Santana, C. F. G. C. Ger-
aldes, B. S. Santos, M. C. P. de Lima, G. A. L. Pereira, A. Fontes, Biochim.
Biophys. Acta Gen. Subj. 2018, 1862, 2788–2796.
[53] F. E. Poynton, S. A. Bright, S. Blasco, D. C. Williams, J. M. Kelly, T. Gunn-
laugsson, Chem. Soc. Rev. 2017, 46, 7706.
[54] J. Marmur, J. Mol. Biol. 1961, 3, 208–218.
[55] M. E. Reichmann, S. A. Rice, C. A. Thomas, P. A. Doty, J. Am. Chem. Soc.
1954, 76, 3047–3053.
[56] L. K. Mapp, L. Fusaro, L. Conti, P. N. Horton, A. Bencini, V. Lippolis, C. Cal-
tagirone, P. A. Gale, R. Montis, C. Giorgi, Chem. Commun. 2019, 55,
2745–2748.
[57] A. Bettoschi, A. Bencini, D. Berti, C. Caltagirone, L. Conti, D. Demurtas,
C. Giorgi, F. Isaia, V. Lippolis, M. Mamusa, S. Murgia, RSC Adv. 2015, 5,
37385–37391.
[58] G. Gran, Analyst 1952, 77, 661.
[59] P. Gans, A. Sabatini, A. Vacca, Talanta 1996, 43, 1739–1753.
[60] R. Schmidt, E. Afshari, J. Phys. Chem. 1990, 94, 4377–4378.
Manuscript received: April 4, 2019
Accepted manuscript online: May 20, 2019
Version of record online: && &&, 0000
Chem. Eur. J. 2019, 25, 1 – 11 www.chemeurj.org  2019 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim10&&
ÝÝ These are not the final page numbers!
Full Paper
FULL PAPER
& Metal Complexes
L. Conti,* A. Bencini, C. Ferrante,
C. Gellini, P. Paoli, M. Parri,
G. Pietraperzia, B. Valtancoli, C. Giorgi*
&& –&&
Highly Charged Ruthenium(II)
Polypyridyl Complexes as Effective
Photosensitizer in Photodynamic
Therapy
Charged for Therapy : Novel RuII and
RuII/CuII mixed polypyridyl complexes
featuring different light-activated mech-
anisms, singlet oxygen generation, and
Fenton-like oxidative pathways were
studied as possible photosensitizers for
photodynamic therapy.
Chem. Eur. J. 2019, 25, 1 – 11 www.chemeurj.org  2019 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim11 &&
These are not the final page numbers! ÞÞ
Full Paper
